Rigel Pharma (RIGL) Receives $25M From AstraZeneca (AZN) for the Achievement of Two Major Milestones in R788 Development
Tweet Send to a Friend
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that they have received a $25 million milestone payment from AstraZeneca (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
